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Introduction
There is wide variation in the cancer survival rates across 
Europe [1], and this leads to substantial excess mortality. 
For example, in Great Britain over 6,000 deaths a year 
that occurred within 5 years of diagnosis would have been 
avoided if survival in Britain had matched the mean for 
Europe [2, 3]; this represents 6-7% of its cancer-related 
mortality.
The variation in 1-year survival rates is even higher. An 
analysis of EUROCARE-4 [4] results by 1-year survival [1] 
shows a group of countries (including Switzerland and 
Sweden) with consistently high survival estimates and 
another group of countries (including England, Slovenia 
and Croatia) with lower estimates. Spain lies near the 
middle of the table. Poor 1-year survival rates are generally 
taken to be an indicator of more advanced disease at 
diagnosis [3]. For those patients that survive at least a year 
after their initial cancer diagnosis, there is less national 
variation. While recent overall cancer survival trends show 
improvement [5], there is little narrowing in the differences 
between countries [6].
International variations in cancer outcomes are related 
to differences in stage at diagnosis, and this may be 
due to differences in diagnostic delay and awareness of 
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Abstract
Objective: To identify the system and other non-clinical factors that may influence a General Practitioners’ decision on whether to refer 
a patient who may have cancer. Study design: Expert group discussion and consensus formation. Methods: A group of eight General 
Practitioner (GP) researchers from Croatia, England, Slovenia, Spain, Sweden and Switzerland used brainstorming to identify the non-
clinical factors that could affect GPs’ decision-making when faced with patients that might have cancer. The group refined and came to a 
consensus on these factors. Results: Many non-clinical factors are likely to have a significant impact on referral decisions. These include 
levels of gatekeeping responsibility, funding systems, access to special investigations, fear of litigation, and relationships with specialist 
colleagues. Conclusions: Many patients with cancer present without red-flag symptoms, but nevertheless still cause a feeling of concern in 
their GPs. How a health system is organised is likely to influence on how GPs act on those concerns. 
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symptoms [7, 8]. However, the challenge of where and how 
to achieve more timely diagnosis is a considerable one [9]. 
A General Practitioner (GP) will see only a handful of new 
cancers in any one year. GPs may go many years, or indeed 
a lifetime, without seeing certain rare cancers. In addition, 
most patients present with evolving and undifferentiated 
symptoms that are more likely to be interpreted as 
something other than cancer.
Various factors can trigger GPs to come to think of cancer 
in a clinical encounter [10]. Awareness of a risk of cancer 
can arise from: practising basic knowledge, for instance 
familiarity with “red-flag” symptoms; interpersonal 
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8awareness, for example being alert to patients’ verbal 
cues; intuitive knowing, e.g. a tacit feeling of alarm; fear of 
cancer, which can affect the thoughts of both doctor and 
patient. However, there is also evidence that system factors 
have an effect on early diagnosis of cancer. Healthcare 
systems with a gatekeeper system have a significantly 
lower 1-year relative cancer survival than systems without 
such gatekeeper functions [11]. It may also be that the way 
in which different healthcare systems support primary 
care in cancer diagnosis by quick and easy access to 
investigations is a factor in delayed cancer diagnosis [12].
There has been a call for better understanding of 
interactions between single health system factors and 
professional behaviour so that outcomes can be improved 
[13]. However, there has been little research to explain 
in which way different national systems influence a GP’s 
referral decisions, and how these may result in such a 
variable survival rate [9].
The aim of the symposium was to identify the system and 
other non-clinical factors that may influence a GP’s decision 
on whether or not to refer a patient who may have cancer. 
The consensus findings are presented in this paper.
Methods
Eight GP researchers from six countries were invited to take 
part in a symposium designed to investigate how primary 
care factors influence the speed of cancer diagnosis. There 
was purposeful selection of delegates from the Örenäs 
Research Group (a European primary care research 
collaborative that investigates the factors influencing the 
speed of cancer diagnosis in primary care) to represent 
northern, southern, central and eastern European 
countries. The symposium took place in Barcelona 
during the 2014 European General Practice Research 
Network (EGPRN) Congress. Participant characteristics are 
summarised in Table 1.
Table 1 Characteristics of participating GPs.
Country of 
practice
Region of 
practice Gender
GP 
expe-
rience 
(years)
Practice setting
Croatia Rijeka Female 10 Urban
England Somerset Male 27 Small town/rural
Slovenia Ljubljana Female 25 Urban
Slovenia Trebnje Female 18 Small town
Spain* Barcelona Female - -
Spain* Mallorca Female - -
Sweden Kronoberg County Male 20 Medium-sized city
Switzerland* Kanton Bern Male 15 Urban and suburban
*Medically qualified GP researchers with no current direct patient contact. 
MH facilitated the two half-days of the symposium. PF 
began session one with a presentation summarising the 
existing evidence on 1-year cancer survival rates and the 
potential role of system factors. Each participant then gave 
a short presentation of the referral roles of GPs in their 
health systems.
The group was given the task of identifying the system 
and other non-clinical factors that could affect a GP’s 
decision-making when faced with a patient that might 
have cancer. For this phase of creative problem-solving, a 
brainstorming technique was used. This method followed 
Osborn’s guidelines [14]: criticism of ideas generated was 
not allowed; “freewheeling” was welcomed; quantity of 
ideas was encouraged; combination and improvement 
were sought. MH had a brief schedule of topics, not 
issued to the participants, which he used to ensure that 
the ideas generated touched on all major areas. In the 
second session, the group discussed, refined, grouped and 
came to a consensus on the previous day’s list of factors. 
Participants captured the ideas on flip-chart pads; during 
the symposium MH also kept notes. These written records 
were used to produce a list of the factors that had been 
identified. 
After the meeting, the list of factors was circulated to 
participants for validation and comment. Participants also 
gave copies to their local GP colleagues for comment. On 
the third iteration of this process, no significant changes 
were requested.
Results
The gatekeeping roles of GPs
The six countries vary in the extent to which their GPs are 
gatekeepers. GPs in Sweden have no gatekeeping role, 
while in Switzerland a third of patients choose a health 
insurance model that uses GPs as gatekeepers. Croatia 
and Slovenia require their GPs to be gatekeepers within 
their public health systems, but private patients in those 
countries can see specialists without a GP referral. In Spain 
and the United Kingdom (UK), GPs have a gatekeeping role 
for all patients (Table 2). Whereas in the UK all GPs routinely 
see children and patients with gynaecological symptoms, 
in the other five countries those patients usually present 
to paediatricians (except in Sweden) and gynaecologists 
instead.
Varying systems for funding medical care
How referrals are financed has a considerable effect on 
referral decisions. Medical systems where referral costs 
are usually met by insurance companies, so do not come 
out of hospital or primary care budgets (Croatia, Slovenia, 
Sweden, Switzerland), are likely to have no inhibitory effect 
on referrals. To some extent that is also the case where 
GPs and specialists share a budget (for instance in Swiss 
managed care systems), so who organises any necessary 
investigations is not important. In two of the participants’ 
health systems, GPs who are considered to have "over-
referred" may find their own income affected (Croatia, 
Spain). Having a budget or quota for specialist referrals 
or diagnostic tests tends to reduce referrals (Croatia and, 
for some tests, Slovenia and Spain). Other health systems 
explicitly put pressure on GPs to reduce referral rates 
(Croatia, Slovenia, Spain, UK).
Referral systems and waiting times
Whereas some health systems encourage GPs to refer 
any patients with possible cancer early, even if there 
is a low risk of cancer (Denmark, Sweden), in others the 
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Country
Are GPs gatekeepers for 
patients seen within the 
public health system?
Are GPs gatekeepers for patients 
who pay for specialist care/are 
seen outside the public health 
system?
Do GPs see 
children?
Do GPs see patients 
with gynaecological 
problems?
Comments
Croatia Yes No
Not usually 
children aged 
below 7 years
No
10% self-refer and pay for 
specialist consultations Patients 
can self-refer for ultrasound and 
some other tests if they pay
England Yes Yes Yes Yes
Slovenia Yes No Not usually No 10% self-refer and pay for specialist consultations
Spain Yes No Not up to age 13 Not usually
25-30% of patients have private 
health insurance
Sweden Partly No Yes Not usually Patients can self-refer to breast clinics
Switzerland About 33% of patients opt for a health insurance model that uses GPs as gatekeepers Not usually Not usually
Some patients are more likely to 
self-refer to specialists
focus is perceived to be on how to save costs by reducing 
the number of referrals (Croatia, Slovenia, UK). Complex 
referral processes may also be a factor in deterring 
referrals (Slovenia, Spain, UK). 
Waiting lists for investigations or specialist appointments 
also affect GP decision-making. Access to a fast-track 
specialist appointment system for patients with suspected 
cancer can be used to encourage referrals (Croatia, Slovenia, 
Spain, UK), while in some of these jurisdictions GPs as a 
whole have been criticised for purportedly overusing that 
system, and asked to use it less (Croatia, Slovenia, UK). 
Long waiting times may result in early referrals, where 
the GP wishes to get patients into the “queue” quickly. 
Conversely, long waits may discourage referral until the 
patient has clear red-flag symptoms or signs, or positive 
investigation results.
Ease of access to investigations
In some jurisdictions (Spain, Switzerland, Germany) 
many GPs can perform in-house specialist investigations 
themselves (for instance diagnostic ultrasound), and in 
some cases they are paid for providing those facilities 
(Switzerland, Germany). This may lower their threshold for 
arranging such investigations. Other medical systems only 
have those investigations available to GPs outside their 
practices. There is variation in how much direct access GPs 
have to such investigations, with some only being available 
via specialist referral.
Relationship with specialist colleagues
The relationship with specialist colleagues is another key 
factor. Whereas in some health systems specialists are 
seen to welcome referrals (Switzerland, and to some extent 
in Sweden), in others they are perceived as discouraging 
them (Croatia, Slovenia, Spain, UK). The ease of being able 
to telephone or email a specialist for informal discussion 
and advice facilitates the care of patients who could have 
cancer (Sweden, Switzerland, and to some extent in Spain), 
as is the ability to refer to a specialist that the GP knows 
personally (Sweden, Switzerland). Having a system that 
prevents the GP from referring to a named specialist may 
have an inhibiting effect on referrals (Croatia, Slovenia, 
Spain, UK).
Fear of litigation or complaint
Fear of litigation, or complaint over a failure to refer, is 
a significant factor in many countries (Croatia, Slovenia, 
Spain, Switzerland, UK). In addition, some GPs may be 
influenced in their decision-making by previous experience 
of criticism from patients or colleagues when a serious 
diagnosis was delayed due to a late referral. The opposite 
experience is also possible, with criticism from patients or 
colleagues who think that the GP should have managed a 
presenting problem without referral (UK). 
Effect of intensity of workload
A high workload may make GPs more likely to refer, in 
an attempt to reduce follow-up appointments (Croatia, 
Slovenia, Spain, UK). However, if there is an expectation 
that the GP will write a detailed, comprehensive referral 
letter, the time taken to do that may discourage the GP 
from making a referral at that appointment (UK). In 
Sweden, where a typical GP appointment is 30 minutes, 
there is more time for patients to mention symptoms 
that concern them, and more time for the GP to consider 
whether investigation or referral is needed.
Clinical guidelines can affect referral decisions
Clinical guidelines can facilitate a GP’s decision to refer, 
by giving advice on which patients need referral because 
of a risk of cancer. However, some delegates reported 
referral guidelines that mainly gave advice on how to avoid 
inappropriate referrals (Croatia, Slovenia, Spain, UK).
Discussion
The readiness of GPs to act consists of personal attributes 
(e.g. knowledge and attitudes about cancer, as well as 
perceptions of the role of GPs) and system factors [15]. This 
symposium identified many system and other non-clinical 
factors that are likely to have a significant impact on referral 
decisions. These include levels of gatekeeping responsibility, 
funding systems, access to special investigations, fear of 
litigation, and relationships with specialist colleagues. A 
recent narrative review was unable to establish a causal 
correlation between healthcare system characteristics and 
cancer outcomes [13]. However, the authors conceded that 
some system factors could have an influence on patient 
and professional behaviour, and consequently contribute 
Harris M et al., J Cancer Res Ther. 2016, 4(1):7-10
10
to differences in cancer outcomes. There is evidence that, 
even when high level features suggest similar healthcare 
systems, there can be considerable variation in the way 
that healthcare is delivered [16].
The symposium’s findings are consistent with studies 
which show that waiting times for tests and lack of referral 
guidelines are among the most important issues related 
to system delay [17, 18]. There is a clear difference in 
decision-making between the systems that have some 
special investigations done by GPs, and those that only 
have them as part of secondary care. In the former, doing 
the investigation is facilitated because it is seen as a quick, 
easy, and possibly income-generating way of making (or 
ruling out) a sinister diagnosis.
While there is a link between European health systems 
where GPs act as gatekeepers and poorer 1-year cancer 
survival rates [11], this symposium found that the degree 
of GPs’ gatekeeping roles varied considerably between 
the participants’ countries. In addition, it may be that 
gatekeeping encourages GPs to use other diagnostic 
strategies, such as the ‘test of time’ [19], which could 
contribute to longer diagnostic intervals [13]. 
The considerable differences in healthcare funding systems 
were also seen by participants to have a clear impact on 
the referral decisions, particularly where a referral can 
affect the GP’s own income, budget or referral quota. 
Some health systems specifically encourage GPs to refer 
patients who may have cancer, even in the absence of red-
flag symptoms. Conversely, some implicitly discourage 
referrals, for example through financial penalties or 
waiting times.
GP decision-making is affected by how much local 
specialists welcome, or discourage, referrals. The level of 
rapport between GPs and those specialists is considered 
to be an important factor, as well as ease of access to 
specialists for advice before a referral decision is made.
Strengths and weaknesses of the approach
This symposium allowed experienced medical practitioners 
from six European countries to generate hypotheses, by 
comparing and contrasting their experiences of how their 
own health systems affect cancer referral decision-making. 
The countries represented are geographically diverse and 
show a wide variation in their 1-year cancer survival rates. 
The findings draw attention to several factors that could 
feasibly contribute to key differences in the speed of 
cancer diagnosis in those countries. The results could 
inform the design of large-scale comparative European 
studies of cancer delay, since they highlight many of the 
variables that such a study must consider if meaningful 
comparisons are to be made.
However, this was a small piece of qualitative work that 
drew on the experience of eight GP researchers. The 
small number of participants involved means that system 
variations in other countries, or within the delegates’ own 
countries, cannot be accounted for, and this may have 
limited the breadth of the findings. 
Conclusions
Although many patients with cancer present without red-
flag symptoms, the GP’s experience or “gut feeling” may 
cause a feeling of concern. How the health system is 
organised is likely to have a strong influence on how the 
GP acts on that concern. The multitude of factors affecting 
decision-making makes it likely that, even in the presence of 
red-flag symptoms, system factors are highly likely to affect 
whether or not a GP refers immediately. Reducing the time 
from presentation to specialist referral or investigation 
is an important step in improving cancer survival. The 
findings of the symposium propose important hypotheses 
on the factors that influence that time, and these warrant 
further research. 
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